On May 1, MediVera Compounding Pharmacy™ hosted a grand opening celebration at its newly unveiled headquarters at 5225 Crooks Rd, Troy, MI 48098. The event commemorated the official opening of the 56,000-square-foot state-of-the-art facility and welcomed community leaders, providers, and partners to tour the space and meet the MediVera team.
The Troy Chamber of Commerce, in collaboration with Mayor Ethan Baker, led the official ribbon-cutting ceremony, honoring MediVera’s growing impact on the local healthcare and business community. Mayor Baker praised the pharmacy’s long-standing dedication to personalized medicine and its role in bringing high-quality healthcare innovation to Troy.
During the event, CEO Bradley McCloskey, PharmD, reflected on MediVera’s 25-year history in the compounding space and shared his vision for the future. “This building is exciting not because of its size alone, but because of what it makes possible. We now have the capacity to serve patients nationwide—people who want personalized medicine to support their health, their goals, their lives.”
The MediVera Compounding Pharmacy™ sign welcomes guests with branded balloon décor during the grand opening celebration at the new Troy facility.
Troy Mayor Ethan Baker addresses guests during the ribbon-cutting ceremony at MediVera Compounding Pharmacy’s™ grand opening celebration on May 1, 2025.
Bradley McCloskey, PharmD, CEO of MediVera Compounding Pharmacy™, speaks with attending healthcare providers during the grand opening celebration, sharing insights on MediVera’s vision and commitment to personalized medicine.
Cutting-Edge Facility Design
Originally announced in March, the new facility significantly expands MediVera’s operational capacity. The 56,000-square-foot space includes advanced ISO-7 cleanrooms and ISO-5 hoods, engineered to meet and exceed USP 795, 797, and 800 guidelines for sterile and non-sterile compounding. These upgrades enable safe and compliant preparation of both hazardous and non-hazardous medications.
MediVera™ currently employs 120 professionals, including nine compounding pharmacists, and invests over $30,000 each month in third-party testing to ensure every compound meets stringent standards for potency and sterility. The pharmacy is PCAB-accredited in both sterile and non-sterile compounding—a distinction held by fewer than 1% of compounding pharmacies in the nation.
Bradley McCloskey, PharmD, CEO of MediVera Compounding Pharmacy™, leads guests on a guided tour of the new Troy facility, highlighting the pharmacy’s state-of-the-art compounding suites and advanced quality systems.
National Reach and Provider-Centered Service
With licenses to operate in and ship to 43 states, MediVera continues to expand its national footprint. The company’s proprietary customer service program—The Impressed Advantage by MediVera Compounding Pharmacy™—includes fast shipping, dedicated account management, clinical education, and patient-first prescription fulfillment.
The May 1st celebration offered a meaningful look back on MediVera’s history—and an exciting step forward in its mission to deliver personalized medicine on a national scale.
43 States: AK, AZ, CO, CT, DE, FL, GA, ID, IL, IA, IN, KS, KY, LA, ME, MD, MA, MI, MN, MO, MT, NE, NH, NJ, NM, NY, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, UT, VA, VT, WA, WV, WI, WY.
About MediVera Compounding Pharmacy™
Founded in 1999, MediVera Compounding Pharmacy™ has been a leader in custom-compounded medications, setting the standard for quality, compliance, and personalized care. The pharmacy partners with healthcare providers across the country to meet patients’ unique therapeutic needs.
